anti-cancer

Eisai: Application for Additional Indication of Anti Cancer Agent Lenvima for Unresectable Thymic Carcinoma Submitted in Japan

New Delhi, August  04, 2020:  Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co., Inc., Kenilworth, N.J.,…

4 years ago

Jan Aushadhi scheme may disrupt domestic pharma market

New Delhi, March 20, 2019: The Jan Aushadhi scheme, under which the government provides quality medicines at affordable rates may disrupt…

6 years ago